Neogen Corporation (NEOG) Financial Statements (2025 and earlier)

Company Profile

Business Address 620 LESHER PLACE
LANSING, MI 48912
State of Incorp. MI
Fiscal Year End May 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

2/28/2025
Q3
11/30/2024
Q2
8/31/2024
Q1
5/31/2024
Q4
2/29/2024
Q3
11/30/2023
Q2
8/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments140,231120,477170,936168,447230,266239,256
Cash and cash equivalent140,231120,477170,611161,437205,765178,832
Short-term investments   3257,01024,50160,424
Receivables164,086167,639173,005173,592150,498137,669
Inventory, net of allowances, customer advances and progress billings198,267198,596189,267182,390160,529140,692
Inventory198,267198,596189,267182,390160,529140,692
Other undisclosed current assets67,86353,93856,02578,04283,08066,176
Total current assets:570,447540,650589,233602,471624,373583,793
Noncurrent Assets
Operating lease, right-of-use asset17,20114,31114,78515,30115,01514,505
Property, plant and equipment310,552300,971277,104272,282244,300221,090
Intangible assets, net (including goodwill)3,135,6643,627,2453,647,2853,676,0823,702,7273,725,668
Goodwill1,672,5012,137,4942,135,6322,136,3382,137,9832,137,602
Intangible assets, net (excluding goodwill)1,463,1631,489,7511,511,6531,539,7441,564,7441,588,066
Regulated entity, other noncurrent assets   11,609   
Deferred income tax assets   3,788   
Other noncurrent assets20,22819,99620,42616,35616,00016,049
Other undisclosed noncurrent assets   (15,397)   
Total noncurrent assets:3,483,6453,962,5233,959,6003,980,0213,978,0423,977,312
TOTAL ASSETS:4,054,0924,503,1734,548,8334,582,4924,602,4154,561,105
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities118,32191,923124,444149,837169,364131,699
Accounts payable79,57461,46483,06189,748112,18490,210
Accrued liabilities38,74730,45941,38360,08957,18041,489
Deferred revenue5,6515,6354,6325,4864,6793,789
Debt2,5762,651902,447   
Accrued environmental loss contingencies  100100   
Other liabilities24,64722,48022,800   
Other undisclosed current liabilities  (100)(900,100)2,5212,5692,642
Total current liabilities:151,195122,689154,323157,844176,612138,130
Noncurrent Liabilities
Long-term debt and lease obligation889,867889,129888,391887,653886,915886,177
Long-term debt, excluding current maturities889,867889,129888,391887,653886,915886,177
Liabilities, other than long-term debt343,960356,979373,093390,821391,321390,623
Deferred income tax liabilities302,405317,574326,718353,853355,005354,792
Accrued environmental loss contingencies  816816   
Other liabilities41,55538,58935,25936,96836,31635,831
Operating lease, liability   10,300   
Other undisclosed noncurrent liabilities  (816)(11,116)   
Total noncurrent liabilities:1,233,8271,245,2921,250,3681,278,4741,278,2361,276,800
Total liabilities:1,385,0221,367,9811,404,6911,436,3181,454,8481,414,930
Equity
Equity, attributable to parent2,669,0703,135,1923,144,1423,146,1743,147,5673,146,175
Common stock34,71234,67234,65834,65734,64434,610
Additional paid in capital2,592,3742,588,9302,583,8852,579,9552,574,9942,571,517
Accumulated other comprehensive loss(44,745)(31,421)(30,021)(29,473)(25,128)(26,496)
Retained earnings86,729543,011555,620561,035563,057566,544
Total equity:2,669,0703,135,1923,144,1423,146,1743,147,5673,146,175
TOTAL LIABILITIES AND EQUITY:4,054,0924,503,1734,548,8334,582,4924,602,4154,561,105

Income Statement (P&L) ($ in thousands)

2/28/2025
Q3
11/30/2024
Q2
8/31/2024
Q1
5/31/2024
Q4
2/29/2024
Q3
11/30/2023
Q2
8/31/2023
Q1
Revenues231,258216,964236,794228,812229,629228,987
Cost of revenue
(Cost of Product and Service Sold)
(117,928)(112,038)(123,312)(111,929)(112,855)(112,226)
Gross profit:113,330104,926113,482116,883116,774116,761
Operating expenses(570,814)(102,669)(100,442)(104,860)(102,309)(97,626)
Operating income (loss):(457,484)2,25713,04012,02314,46519,135
Nonoperating expense(19,088)(17,866)(19,439)(17,845)(18,212)(17,472)
Interest and debt expense   (10,787)(10,497)(10,267)(10,601)
Loss from continuing operations before equity method investments, income taxes:(476,572)(15,609)(17,186)(16,319)(14,014)(8,938)
Other undisclosed income from continuing operations before income taxes   10,78710,49710,26710,601
Income (loss) from continuing operations before income taxes:(476,572)(15,609)(6,399)(5,822)(3,747)1,663
Income tax expense (benefit)20,2903,0009843,800260(160)
Net income (loss) available to common stockholders, diluted:(456,282)(12,609)(5,415)(2,022)(3,487)1,503

Comprehensive Income ($ in thousands)

2/28/2025
Q3
11/30/2024
Q2
8/31/2024
Q1
5/31/2024
Q4
2/29/2024
Q3
11/30/2023
Q2
8/31/2023
Q1
Net income (loss):(456,282)(12,609)(5,415)(2,022)(3,487)1,503
Other comprehensive income (loss)(13,324)(1,400)(548)(4,345)1,3686,755
Comprehensive income (loss), net of tax, attributable to parent:(469,606)(14,009)(5,963)(6,367)(2,119)8,258

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: